fda glp-1 compounding warning september 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of medications like semaglutide and tirzepatide, signaling a major shift in how these What Patients Need to Know

This is best achieved with either multiple dose injection of subcutaneous basal insulin analogues and mealtime rapid-acting or ultra-rapid-acting insulin analogues, or with continuous subcutaneous insulin infusion of a rapid-acting insulin analogue via a pump, delivered as continuous basal insulin combined with manual mealtime boluses

Saxenda is sometimes prescribed off-label for metabolic dysfunction-associated steatohepatitis (MASH)

141 If dietary strategies are insufficient, other therapies include daily magnesium supplementation, titrated to keep bowel movements regular

Potential Side Effects While GLP-1 medications are generally well tolerated, there are potential side effects to be aware of

Although all of these are considered beneficial and protective mechanisms, there is still some debate about the frequent adverse effects (AE) they have, most of them of gastrointestinal nature (151, 152)

3 Take home message Second Nature and WeightWatchers serve different needs when it comes to GLP-1 weight-loss treatment in the UK